Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008;168:826-831. Data from the Group Health Atrial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Alendronate, a drug commonly used to treat osteoporosis, ...

Please provide your email address to receive an email when new articles are posted on . Denosumab as a first-line osteoporosis therapy is linked to lower fracture risks than alendronate among ...

A new study analyzing health records from several hundred thousand people in Denmark has identified a link between low rates of type 2 diabetes and osteoporosis patients treated with a drug called ...

A recent review of alendronate for the treatment of glucocorticoid-induced osteoporosis (GIO) found that it significantly increased bone mineral density of the lumbar spine and femoral neck in ...

--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...

Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re one of the 8 million American women with osteoporosis, your doctor has probably talked to you about treatment options to ...

Real World Evidence Study Showed use of Prolia Reduced Fracture Risk in Postmenopausal Women With Osteoporosis Versus Alendronate Treatment Longer Duration of Treatment With Prolia Was Associated With ...